Cowen Upgrades Novartis (NVS) to Outperform
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $154.55 --0%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Cowen upgraded Novartis (NYSE: NVS) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Novartis click here. For more ratings news on Novartis click here.
Shares of Novartis closed at $92.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
- TD Cowen Upgrades BRP Inc. (DOOO) to Buy
- Avita Medical Ltd. (RCEL) PT Raised to $14 at TD Cowen
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
